BLOOD RESEARCH

pISSN 2287-979X
eISSN 2288-0011

Download original image
Table 2Therapeutic responses to eltrombopag.

a)Initial required doses to achieve target platelet count (≥50,000 cells/mL, N=13). b)Doses to maintain target platelet count (≥ 50,000 cells/mL, N=13).

Abbreviations: EOD, every other day; RFS, relapse-free survival.

Blood Res 2015;50:19~25 https://doi.org/10.5045/br.2015.50.1.19
© Blood Res